SBRA: financial statements from SEC — TradeAlmanac

SBRA

Sabra Health Care REIT, Inc.: financial statements

Company reports as filed with the U.S. Securities and Exchange Commission.

AnnualQuarterly

Income statement

Metric	Mar 31, 2026	Sep 30, 2025	Jun 30, 2025	Mar 31, 2025	Sep 30, 2024	Jun 30, 2024
Revenue	222m	190m	189m	184m	178m	176m
Selling, general and administrative	15m	13m	13m	13m	12m	13m
Interest expense	28m	29m	28m	27m	29m	29m
Pre-tax income	39m	22m	65m	40m	29m	24m
Income tax	526,000	436,000	497,000	413,000	−265,000	437,000
Net income	41m	23m	66m	40m	30m	24m
Earnings per share	0.16	0.09	0.28	0.17	0.13	0.10
Earnings per share, diluted	0.16	0.09	0.27	0.17	0.13	0.10
Weighted average shares	252m	240m	238m	238m	234m	232m
Weighted average shares, diluted	256m	244m	241m	240m	237m	234m

Balance sheet

Metric	Mar 31, 2026	Dec 31, 2025	Sep 30, 2025	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024
Cash and equivalents	117m	72m	201m	95m	23m	60m	69m	42m
Total assets	5.59bn	5.49bn	5.56bn

Cash flow

Metric	Mar 31, 2026	Sep 30, 2025	Jun 30, 2025	Mar 31, 2025	Sep 30, 2024	Jun 30, 2024
Operating cash flow	98m	—	—	80m	—	—
Depreciation and amortisation	53m	49m	44m	43m

Amounts in USD unless stated otherwise. Sources: Nasdaq Trader, Yahoo Finance, U.S. Securities and Exchange Commission (EDGAR)